Fukuda Denshi (6960) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Sep, 2025Executive summary
Net sales for FY ended March 31, 2025 were ¥139,007 million, down 0.9% year-over-year.
Operating profit decreased 2.4% to ¥25,874 million, and profit attributable to owners of parent fell 0.5% to ¥18,605 million.
The business environment was marked by economic recovery but ongoing uncertainty due to rising resource prices and global trade friction.
Financial highlights
Gross profit was ¥73,816 million, with a gross margin of 53.1%.
Earnings per share rose to ¥645.41, up 3.7% year-over-year.
Comprehensive income dropped 20% to ¥18,160 million.
Cash and cash equivalents at year-end increased to ¥67,348 million.
Annual dividend per share was ¥195.00, with a payout ratio of 30.2%.
Outlook and guidance
FY2026 forecast: net sales ¥137,000 million (down 1.4%), operating profit ¥24,000 million (down 7.2%), profit attributable to owners of parent ¥17,000 million (down 8.6%), EPS ¥589.68.
Dividend forecast for FY2026 is ¥180.00 per share.
Latest events from Fukuda Denshi
- Slight YoY profit decline offset by strong comprehensive income and stable full-year outlook.6960
Q3 20265 Feb 2026 - Net sales up 0.8% and operating profit steady, with segment shifts and stable full-year outlook.6960
Q2 202612 Nov 2025 - Sales rose 4% year-over-year, but profits declined; full-year guidance and dividends unchanged.6960
Q1 20259 Sep 2025 - First-half profits fell on lower sales, but full-year guidance and dividend plans remain unchanged.6960
Q2 20259 Sep 2025 - Profits declined despite stable sales, with mixed segment performance and steady full-year outlook.6960
Q3 20259 Sep 2025 - Profits declined despite stable sales; medical treatment and consumables segments showed growth.6960
Q1 20269 Sep 2025